Literature DB >> 28876496

Seroprevalence and incidence of hepatitis E virus among blood donors: A review.

Duaa W Al-Sadeq1, Amin F Majdalawieh2, Gheyath K Nasrallah1,3.   

Abstract

Hepatitis E virus (HEV) is an RNA virus with 4 main genotypes. HEV-1 and HEV-2 infect solely humans, while HEV-3 and HEV-4 infect humans and various animals such as pigs, deer, and rabbits. HEV-5 and HEV-6 infect mainly wild boar. Recently, new genotypes, known as HEV-7 and HEV-8, were found to infect camels and humans. HEV is globally distributed into different epidemiological patterns based on socioeconomic factors and ecology. Although HEV is mainly transmitted through the fecal-oral route, it was also recognized as a transfusion-transmitted virus. Transmission through blood donation was documented worldwide with rising annual observations, accounting for more than 2.5% of all transmissions. HEV infection is usually asymptomatic or subclinical in immunocompetent individuals, so it remains questionable whether there is an urgent need to screen for HEV prior to blood transfusion. Moreover, recent studies conducted in the Middle East and North Africa (MENA) region indicate that HEV is highly endemic. Here, we provide a review on HEV epidemiology, transmission, and laboratory diagnosis, giving special emphasis to the newly discovered genotypes, HEV-7 and HEV-8. Furthermore, we underscore the findings of recent HEV seroprevalence and viremia studies among blood donors worldwide. We also shed light on similar studies performed among blood donors in the MENA region.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HEV; blood donors; seroprevalence; transfusion; viremia

Year:  2017        PMID: 28876496     DOI: 10.1002/rmv.1937

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  7 in total

Review 1.  Hiding in Plain Sight? It's Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries.

Authors:  Nicola J King; Joanne Hewitt; Anne-Marie Perchec-Merien
Journal:  Food Environ Virol       Date:  2018-04-05       Impact factor: 2.778

2.  Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India.

Authors:  Harshita Katiyar; Amit Goel; Atul Sonker; Vishwajeet Yadav; Sadul Sapun; Rajendra Chaudhary; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2018-08-29

Review 3.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

4.  Clinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt.

Authors:  Ibrahim M Sayed; Mohamed A El-Mokhtar; Mahmoud Abdel Rahman Mahmoud; Amal A Elkhawaga; Shereen Gaber; Nermien H Seddek; Lobna Abdel-Wahid; Ahmed M Ashmawy; Enas Ahmed Reda Alkareemy
Journal:  Infect Drug Resist       Date:  2021-01-12       Impact factor: 4.003

5.  The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.

Authors:  Ronnie Kasirye; Heather A Hume; Evan M Bloch; Irene Lubega; Dorothy Kyeyune; Ruchee Shrestha; Henry Ddungu; Hellen Wambongo Musana; Aggrey Dhabangi; Joseph Ouma; Priscilla Eroju; Telsa de Lange; Michael Tartakovsky; Jodie L White; Ceasar Kakura; Mary Glenn Fowler; Philippa Musoke; Monica Nolan; M Kate Grabowski; Lawrence H Moulton; Susan L Stramer; Denise Whitby; Peter A Zimmerman; Deo Wabwire; Isaac Kajja; Jeffrey McCullough; Raymond Goodrich; Thomas C Quinn; Robert Cortes; Paul M Ness; Aaron A R Tobian
Journal:  Trials       Date:  2022-04-04       Impact factor: 2.279

6.  Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.

Authors:  Qiang Zhang; Xiaolong Zong; Dongming Li; Jing Lin; Lihua Li
Journal:  Pol J Microbiol       Date:  2020-06-04

7.  The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E.

Authors:  Enas S Al Absi; Duaa W Al-Sadeq; Makiyeh Khalili; Nadin Younes; Nader Al-Dewik; Sara K Abdelghany; Somaia S Abouzid; Asma A Al Thani; Hadi M Yassine; Peter V Coyle; Gheyath K Nasrallah
Journal:  BMC Gastroenterol       Date:  2021-06-15       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.